Clinical trial
An Ascending Dose Tolerability Study and Pharmacokinetic Assessment in Healthy Male and Female Volunteers After Single & Multiple Oral Administration of DF2755A
NCT04803396 is registered in ClinicalTrials.gov with Dompé Farmaceutici S.p.A as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Ascending Dose Tolerability Study and Pharmacokinetic Assessment in Healthy Male and Female Volunteers After Single & Multiple Oral Administration of DF2755A
- Lead sponsor
- Dompé Farmaceutici S.p.A
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- November 15, 2018
- Completion date
- June 29, 2019
- Enrollment
- 32 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
no condition